文献速递MDS 与骨髓增殖性肿瘤血栓与止血

JAK2V617F骨髓增殖性肿瘤中中性粒细胞清除缺陷通过免疫检查点CD24驱动骨髓纤维化

Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24.
PubMed 文献 · Blood · 2025-01-01

该研究探讨骨髓增殖性肿瘤(MPN)中中性粒细胞稳态与细胞互作,发现JAK2V617F MPN衰老中性粒细胞逃避清除并积聚,依赖GM-CSF-JAK2-STAT5上调CD24;CD24hi中性粒细胞侵入巨核细胞并增加活性TGF-β,促进血小板生成和骨髓纤维化;CD24阻断可恢复清除并改善血栓增多、预防纤维化。

要点

  • JAK2V617F MPN中衰老中性粒细胞逃避稳态清除而积聚,CALR突变MPN无此现象。
  • CD24上调依赖GM-CSF-JAK2-STAT5,CD24hi中性粒细胞逃避胞葬并侵入巨核细胞。
  • CD24阻断或基因缺失恢复中性粒细胞清除,改善血栓增多并预防小鼠骨髓纤维化。

核心结论

  • 中性粒细胞清除缺陷是MPN中炎症性中性粒细胞与巨核细胞致病性微环境互作的原因,与骨髓纤维化相关。
  • 研究提出CD24作为MPN候选先天免疫检查点。

研究设计与样本

  • 研究纳入MPN患者样本,比较JAK2V617F MPN与钙网蛋白基因突变MPN的中性粒细胞稳态。
  • 采用人源化生物反应器和小鼠模型进行机制与干预实验。

主要发现

  • 衰老中性粒细胞在JAK2V617F MPN中逃避稳态清除并积聚,而在钙网蛋白基因突变MPN中无此现象。
  • JAK2V617F CD24hi中性粒细胞逃避胞葬、侵入巨核细胞并增加活性TGF-β。
  • JAK2V617F中性粒细胞-巨核细胞互作在人源化生物反应器中促进血小板生成,在小鼠模型中促进骨髓纤维化。
  • 慢性抗体阻断或CD24基因缺失恢复衰老中性粒细胞清除,减少侵入巨核细胞现象和活性TGF-β。
  • CD24阻断改善MPN小鼠血栓增多并预防骨髓纤维化。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myeloproliferative neoplasms (MPNs) are hematopoietic stem cell-driven malignancies marked by excessive myelopoiesis and high risk of myelofibrosis, which remains therapeutically challenging. Senescent neutrophils home daily to the bone marrow (BM) to be cleared by macrophages. This avoids their accumulation, which can increase the risk of chronic inflammation or oncogenesis. Neutrophils carrying the most common oncogenic MPN driver (JAK2V617F) are protected from apoptosis, which may prolong their life span and enhance their proinflammatory activity. In contrast, abnormal interactions of neutrophils with megakaryocytes ("emperipolesis") have been associated with BM fibrosis in disparate hematologic disorders, including MPN and gray platelet syndrome; however, the underlying pathophysiology remains unclear. We investigated neutrophil homeostasis and cellular interactions in MPN. We found that senescent neutrophils evade homeostatic clearance and accumulate in JAK2V617F MPN, but not in MPN caused by the second most prevalent mutations affecting calreticulin gene. This is explained by granulocyte-macrophage colony-stimulating factor-JAK2-STAT5-dependent upregulation of the "don't eat me" signal CD24 in neutrophils. Mechanistically, JAK2V617F CD24hi neutrophils evade efferocytosis, invade megakaryocytes, and increase active transforming growth factor β (TGF-β). Collectively, JAK2V617F neutrophil-megakaryocyte interactions promote platelet production in a humanized bioreactor and myelofibrosis in mouse models. Notably, chronic antibody blockade or genetic loss of CD24 restores clearance of senescent neutrophils and reduces emperipolesis and active TGF-β. Consequently, CD24 blockade improves thrombocytosis and prevents myelofibrosis in MPN mice. Taken together, these findings reveal defective neutrophil clearance as a cause of pathogenic microenvironmental interactions of inflammatory neutrophils with megakaryocytes, associated with myelofibrosis in MPN. Our study postulates CD24 as a candidate innate immune checkpoint in MPN.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Khatib-Massalha E, Di Buduo CA, Chédeville AL, et al. Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24. Blood. 2025. PMID: 40373279. doi:10.1182/blood.2024027455

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。